Cargando…

Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study

BACKGROUND: Patients with combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) are not traditionally considered eligible for liver transplantation (LT) due to poor outcomes. AIM: To compare outcomes between living donor LT (LDLT) patients with hepatocellular carcinoma (HCC) and LT pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jongman, Joo, Dong-Jin, Hwang, Shin, Lee, Jeong-Moo, Ryu, Je-Ho, Nah, Yang-Won, Kim, Dong-Sik, Kim, Doo-Jin, You, Young-Kyoung, Yu, Hee-Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Case Control Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405106/ https://www.ncbi.nlm.nih.gov/pubmed/37555110 http://dx.doi.org/10.4240/wjgs.v15.i7.1340

Ejemplares similares

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database
por: Kang, Woo-Hyoung, et al.
Publicado: (2022)

Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Yang, Jie, et al.
Publicado: (2020)

Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma
por: Kim, Minjae, et al.
Publicado: (2021)

A Case of Combined Hepatocellular-Cholangiocarcinoma with Underlying Schistosomiasis
por: Hong, Chang Kyun, et al.
Publicado: (2007)

Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study
por: Kim, Deok Gie, et al.
Publicado: (2022)

Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry
por: Kim, Jong Man, et al.
Publicado: (2021)

Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database
por: Park, Gil-Chun, et al.
Publicado: (2020)

Invasive fungal infection in liver transplant recipients in a prophylactic era: A multicenter retrospective cohort study in Korea
por: Kim, Youn Jeong, et al.
Publicado: (2019)

Fatty liver is an independent risk factor for gallbladder polyps
por: Ahn, Dong-Won, et al.
Publicado: (2020)

Polymorphism of genes encoding drug-metabolizing and inflammation-related enzymes for susceptibility to cholangiocarcinoma in Thailand
por: You, Gyokukou, et al.
Publicado: (2023)

Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial
por: Kim, So Jeong, et al.
Publicado: (2019)

Clinicopathological Characteristics in Combined Hepatocellular-Cholangiocarcinoma: A Single Center Study in Korea
por: Park, Hana, et al.
Publicado: (2011)

Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
por: Choi, Youn I, et al.
Publicado: (2021)

A Case of Biliary Cast Syndrome with Cholangiocarcinoma-like Lesion in a Patient with No History of Liver Transplantation
por: Jo, Sa-Hong, et al.
Publicado: (2023)

Postresection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma according to the 2010 World Health Organization classification: single-center experience of 168 patients
por: Kim, Minjae, et al.
Publicado: (2021)

Impact of carotid atherosclerosis detection on physician and patient behavior in the management of type 2 diabetes mellitus: a prospective, observational, multicenter study
por: Jeong, In-Kyung, et al.
Publicado: (2016)

Proposed Modification of Staging for Distal Cholangiocarcinoma Based on the Lymph Node Ratio Using Korean Multicenter Database
por: You, Yunghun, et al.
Publicado: (2020)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
por: Kim, Jong Man, et al.
Publicado: (2021)

Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)

Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study
por: Corey, Kathleen E, et al.
Publicado: (2017)

Long-Term Outcomes of Liver Transplantation in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Comparison with Portal Vein Tumor Thrombus
por: Lee, Ji Soo, et al.
Publicado: (2023)

A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
por: Kim, Gun Min, et al.
Publicado: (2010)

Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Choi, Mun Chae, et al.
Publicado: (2022)

Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma
por: Kobayashi, Satoshi, et al.
Publicado: (2018)

Efficacy of image-enhanced endoscopy for colorectal adenoma detection: A multicenter, randomized trial
por: Qi, Zhi-Peng, et al.
Publicado: (2023)

Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2022)

Bile Duct Patency Maintained after Intraductal Radiofrequency Ablation in a Case of Hepatocellular Cholangiocarcinoma with Bile Duct Invasion
por: Han, Sung Yong, et al.
Publicado: (2018)

Liver Transplantation for Incidental Cholangiocarcinoma or Combined Hepatocellular Carcinoma/Cholangiocarcinoma—Own Experiences and Review of the Literature
por: Schwenk, Laura, et al.
Publicado: (2023)

High-Dose Fentanyl Patch for Cancer Pain of a Patient with Cholangiocarcinoma
por: Kim, Jung Han, et al.
Publicado: (2010)

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
por: Kang, Incheon, et al.
Publicado: (2021)

Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study
por: Akbulut, Sami, et al.
Publicado: (2022)

Association between homeobox protein transcript antisense intergenic ribonucleic acid genetic polymorphisms and cholangiocarcinoma
por: Lampropoulou, Dimitra Ioanna, et al.
Publicado: (2021)

Correction: Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2023)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
por: Noh, Sang Jae, et al.
Publicado: (2012)

Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study
por: Jo, Hye-Sung, et al.
Publicado: (2020)

Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinoma
por: Park, Sang Eun, et al.
Publicado: (2013)

A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult
por: Park, Keun Woo, et al.
Publicado: (2015)

Liver transplantation versus resection for patients with combined hepatocellular cholangiocarcinoma: A retrospective cohort study
por: Mi, Shizheng, et al.
Publicado: (2023)

Introduction of Lens-angle Reconstruction Surgery in Rabbit Eyes
por: Kim, Min Hee, et al.
Publicado: (2014)

Descriptive Epidemiology of Cholangiocarcinoma and Clonorchiasis in Korea
por: Shin, Hai-Rim, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_cgg6r57ftqmfljp176drl20icg